Fosun International LTD Soleno Therapeutics Inc Transaction History

Fosun International LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$1.5 - $2.99 $283,473 - $565,056	-188,982 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$1.35 - $2.68 $11,568 - $22,964	8,569 Added 4.75%	188,982 $397,000
Q4 2018 Jan 31, 2019	BUY	$1.55 - $2.3 $279,640 - $414,949	180,413 New	180,413 $294,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $451M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.